13F HOLDINGS REPORT (Amended)
Opaleye Management Inc.
Quarter ended Q1 2024 · Filed May 29, 2024 · Accession 0001493152-24-021780
Total Value
$458.9M
Positions
52
Other Managers
0
Confidential Omitted
No
Holdings (52)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | OCULAR THERAPEUTIX INC | OCUL | 6,653,138 | $60.5M | 13.19% |
| 2 | HARROW HEALTH INC | HROW | 3,920,600 | $51.9M | 11.30% |
| 3 | TG THERAPEUTICS INC | TGTX | 2,280,000 | $34.7M | 7.56% |
| 4 | KEROS THERAPEUTICS INC | KROS | 367,500 | $24.3M | 5.30% |
| 5 | RHYTHM PHARMACEUTICALS INC | RYTM | 515,000 | $22.3M | 4.86% |
| 6 | CATALYST PHARMACEUTICALS INC | CPRX | 1,004,355 | $16.0M | 3.49% |
| 7 | ARVINAS INC | ARVN | 330,000 | $13.6M | 2.97% |
| 8 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 897,000 | $13.3M | 2.90% |
| 9 | JASPER THERAPEUTICS INC | JSPRW | 435,573 | $12.8M | 2.79% |
| 10 | EDGEWISE THERAPEUTICS INC | EWTX | 665,000 | $12.1M | 2.64% |
| 11 | APPLIED THERAPEUTICS | 03828A101 | 1,770,000 | $12.0M | 2.62% |
| 12 | 4D MOLECULAR THERAPEUTICS INC | FDMT | 344,123 | $11.0M | 2.39% |
| 13 | CODEXIS INC | CDXS | 3,120,000 | $10.9M | 2.37% |
| 14 | PROTARA THERAPEUTICS INC | TARA | 2,692,594 | $10.8M | 2.35% |
| 15 | ACELYRIN INC | 00445A100 | 1,580,000 | $10.7M | 2.32% |
| 16 | CRINETICS PHARMACEUTICALS INC | CRNX | 210,000 | $9.8M | 2.14% |
| 17 | ETON PHARMACEUTICALS INC | ETON | 2,445,781 | $9.2M | 2.00% |
| 18 | TREVI THERAPEUTICS INC | TRVI | 2,645,000 | $9.1M | 1.99% |
| 19 | LYELL IMMUNOPHARMA INC | LYEL | 3,355,000 | $7.5M | 1.63% |
| 20 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 315,388 | $7.5M | 1.63% |
| 21 | VENTYX BIOSCIENCES INC | 92332V107 | 1,285,000 | $7.1M | 1.54% |
| 22 | INTELLIA THERAPEUTICS INC | NTLA | 255,000 | $7.0M | 1.53% |
| 23 | COMPASS THERAPEUTICS INC | CMPX | 3,170,000 | $6.3M | 1.37% |
| 24 | XOMA CORP DEL | XOMAP | 250,000 | $6.0M | 1.31% |
| 25 | LIQUIDIA CORPORATION | LQDA | 395,000 | $5.8M | 1.27% |
| 26 | VAXCYTE INC | PCVX | 85,000 | $5.8M | 1.27% |
| 27 | NYXOAH S A | NYXH | 320,000 | $4.3M | 0.94% |
| 28 | SAVARA INC | SVRA | 855,000 | $4.3M | 0.93% |
| 29 | SYROS PHARMACEUTICALS INC | 87184Q206 | 787,545 | $4.2M | 0.92% |
| 30 | UROGEN PHARMA LTD | URGN | 270,000 | $4.0M | 0.88% |
| 31 | NURIX THERAPEUTICS INC | NRIX | 267,210 | $3.9M | 0.86% |
| 32 | REVANCE THERAPEUTICS INC | 761330109 | 785,000 | $3.9M | 0.84% |
| 33 | RELMADA THERAPEUTICS INC | RLMD | 759,000 | $3.5M | 0.77% |
| 34 | PROTAGONIST THERAPEUTICS INC | PTGX | 112,700 | $3.3M | 0.71% |
| 35 | GOSSAMER BIO INC | GOSS | 8,000,000 | $3.2M | 0.70% |
| 36 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 200,000 | $3.2M | 0.69% |
| 37 | ALLAKOS INC | 01671P100 | 2,435,000 | $3.1M | 0.67% |
| 38 | GOSSAMER BIO INC | GOSS | 2,440,109 | $2.9M | 0.63% |
| 39 | IBIO INC | IBIO | 680,000 | $2.8M | 0.60% |
| 40 | VERASTEM INC | VSTM | 211,400 | $2.5M | 0.54% |
| 41 | ALIGOS THERAPEUTICS INC | ALGS | 1,630,000 | $1.6M | 0.35% |
| 42 | CONTEXT THERAPEUTICS INC | CNTX | 1,108,357 | $1.5M | 0.33% |
| 43 | PRECIGEN INC | PGEN | 947,500 | $1.4M | 0.30% |
| 44 | LARIMAR THERAPEUTICS INC | LRMR | 174,413 | $1.3M | 0.29% |
| 45 | FULCRUM THERAPEUTICS INC | FULC | 130,000 | $1.2M | 0.27% |
| 46 | MORPHOSYS AG | 617760202 | 65,000 | $1.2M | 0.26% |
| 47 | GLAUKOS CORP | GKOS | 8,576 | $808,631 | 0.18% |
| 48 | PMV PHARMACEUTICALS INC | PMVP | 471,481 | $802,130 | 0.17% |
| 49 | BIODESIX | BDSX | 534,657 | $764,560 | 0.17% |
| 50 | REGULUS THERAPEUTICS INC | 75915K309 | 170,308 | $490,487 | 0.11% |
| 51 | DESIGN THERAPEUTICS INC | DSGN | 113,038 | $455,543 | 0.10% |
| 52 | REPARE THERAPEUTICS iNC | 760273102 | 67,561 | $318,212 | 0.07% |